Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

0.7500 UNCHANGED
Streaming Delayed Price Updated: 3:47 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genetic Tech Spn ADR

< Previous 1 2 3 4 5 6 7 8 Next >
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Marijuana Stock Movers For May 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For May 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
GeneType and Humanise Health host “Know Your Risk” Event
From Genetic Technologies Ltd
Via GlobeNewswire
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
From Genetic Technologies Ltd
Via GlobeNewswire
Appendix 4C & Quarterly Business Update – March 2024
Launching our most comprehensive test and expanding into new global markets 
From Genetic Technologies Ltd
Via GlobeNewswire
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Movers For April 19, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 18, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Genetic Technologies Announces $2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Gainers And Losers From April 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
From Genetic Technologies Ltd
Via GlobeNewswire
Bearish Monday For Marijuana Stocks - AusCann Group Holdings, Target Group Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Marijuana Stock Movers For April 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.